Atlas Trials

Profiling of Circulating Immune Cells to Uncover Response Signatures to Anti-PD1 Immunotherapy in Melanoma Patients

Clinical trial NCT06154668 · RECRUITING

Trial details

NCT number
NCT06154668
Sponsor
University Hospital, Grenoble
Status
RECRUITING
Study type
OBSERVATIONAL
Melanoma
Start date
2024-01-17
Primary completion
2030-01-01
Enrollment
707

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.